Liraglutide Dosage Chart: How Dosing Works
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 24th, 2026.
Published on July 22nd, 2026. Updated on July 24th, 2026.
Key takeaways
The 0.6 mg starting dose is universal for both Victoza and Saxenda and exists solely to reduce GI side effects, not to provide therapeutic benefit.
Victoza and Saxenda contain the same molecule but have different FDA-approved maintenance dose ceilings based on their separate indications.
Saxenda titration takes a minimum of five weeks to reach the 3.0 mg target dose when followed as recommended.
Slowing titration due to nausea or other side effects is a standard clinical strategy, not a sign of treatment failure.
A 16-week weight loss checkpoint at the full 3.0 mg Saxenda dose is a guideline-backed decision point for reassessing continuation.
What Liraglutide Is and Why Dosing Matters
Liraglutide is a GLP-1 receptor agonist, a type of medication that mimics a natural hormone involved in blood sugar regulation and appetite control. You may know it by its brand names: Victoza, approved for type 2 diabetes management, and Saxenda, approved for chronic weight management. Importantly, both products contain the exact same molecule. What differs is the approved dose ceiling and the clinical indication.
Because liraglutide works by gradually influencing how your body processes glucose and signals fullness, dosing is not one-size-fits-all. Moving through doses too quickly can cause significant nausea, vomiting, or diarrhea that may push patients to stop treatment early. Staying at too low a dose for too long may mean missing the therapeutic benefits the medication is designed to provide. The structured titration schedule exists to balance those two risks.
The Standard Titration Schedule
Regardless of whether liraglutide is being used for diabetes or weight loss, the starting dose is always 0.6 mg once daily, injected subcutaneously. This initial dose is not expected to produce meaningful blood sugar lowering or weight loss on its own. Its sole purpose is to allow the GI tract to adjust, reducing the likelihood of uncomfortable side effects.
After one week at 0.6 mg, the dose is typically increased by 0.6 mg increments at weekly intervals, as tolerated. For Victoza users, the escalation moves from 0.6 mg to 1.2 mg and potentially to 1.8 mg. For Saxenda users, the titration continues further, progressing through 1.2 mg, 1.8 mg, 2.4 mg, and finally 3.0 mg as the target maintenance dose.
If side effects arise at any step, the prescriber may choose to extend the current dose for an additional week or two before moving forward. This is a routine clinical approach and does not indicate treatment failure.
Victoza Dosing for Type 2 Diabetes
For people using Victoza to manage blood sugar, the maintenance dose for glycemic control is 1.2 mg once daily. Many patients achieve meaningful A1c reductions at this level. If additional glucose lowering is needed, the dose may be increased to 1.8 mg per day, which is the maximum approved dose for the diabetes indication.
Important considerations for Victoza users include interactions with other glucose-lowering agents. When liraglutide is added to a regimen that already includes a sulfonylurea or insulin, those existing medications may need dose reductions to prevent hypoglycemia. The adjustment is typically made to the other agent, not to liraglutide itself. Patients with hepatic impairment should be monitored closely, as limited data exist for this population.
Saxenda Dosing for Weight Management
Saxenda titration extends beyond the diabetes ceiling, targeting 3.0 mg daily as the full maintenance dose. Reaching that target following the standard weekly step-up schedule takes a minimum of five weeks from the initial 0.6 mg dose.
Once a patient reaches 3.0 mg, there is a meaningful checkpoint built into the clinical guidelines. At 16 weeks on the full dose, if a patient has not lost at least 4% of their baseline body weight, guidelines suggest reassessing whether continuation is appropriate. This checkpoint is evidence-based and designed to help clinicians and patients make informed decisions together, not to create pressure or judgment around results.
If tolerability is a concern at any step, extending time at a given dose rather than discontinuing is the preferred clinical strategy. The goal is to reach the most effective dose each patient can sustain comfortably.
Factors That Shape Your Individual Dosing Plan
Several factors may influence how quickly or slowly a prescriber moves through the titration schedule, or how they manage your overall plan.
GI side effects, particularly nausea and vomiting, are the most common reasons for slowing titration. Taking liraglutide with food, staying well hydrated, and avoiding high-fat meals during dose escalation can all help manage tolerability.
Kidney function is another consideration. While the prescribing label does not formally require dose adjustments for renal impairment, severe kidney disease warrants clinical caution. Liraglutide has not been adequately studied in patients on dialysis, so prescribers will weigh the risks carefully for this population.
Concomitant medications that lower blood sugar also factor in. As noted above, sulfonylureas or insulin doses may need adjustment when liraglutide is introduced, to reduce the risk of low blood sugar episodes.
How Liraglutide Compares to Other GLP-1 Medications
Liraglutide is one of several GLP-1 receptor agonists available today. Understanding how it differs from alternatives can help patients and caregivers have more informed conversations with their prescribers.
Medication |
Injection Frequency |
Starting Dose |
Maximum Dose |
Primary Indication |
|---|---|---|---|---|
Liraglutide (Victoza/Saxenda) |
Daily |
0.6 mg |
1.8 mg (diabetes) / 3.0 mg (weight loss) |
Type 2 diabetes, weight management |
Semaglutide (Ozempic/Wegovy) |
Weekly |
0.25 mg |
2.0 mg (diabetes) / 2.4 mg (weight loss) |
Type 2 diabetes, weight management |
Dulaglutide (Trulicity) |
Weekly |
0.75 mg |
4.5 mg |
Type 2 diabetes |
Semaglutide offers a weekly injection schedule, which some patients find more convenient, along with a different titration timeline. Dulaglutide also requires only weekly injections and follows a simpler two-step titration, though it is currently approved only for diabetes and not for weight management. Each medication has its own tolerability profile and practical considerations. Doctronic's platform, which has supported more than 22 million AI consultations, can help you explore how these options compare based on your specific situation.
When discussing GLP-1 options with a clinician, factors like injection frequency preference, insurance coverage, and individual health history all play a role in determining the best fit. No single medication works identically for every person, and dosing flexibility within each option matters just as much as the medication itself.
Frequently Asked Questions
The starting dose of liraglutide for weight loss (Saxenda) is 0.6 mg once daily for the first week. This lower starting dose is used to help your body adjust and reduce common GI side effects like nausea. From there, the dose is gradually increased every week until reaching the 3.0 mg maintenance target.
Following the standard titration schedule, it takes a minimum of five weeks to reach the 3.0 mg target dose. Patients move through 0.6 mg, 1.2 mg, 1.8 mg, and 2.4 mg steps, each lasting one week, before reaching the full maintenance dose. If side effects are a concern, a prescriber may extend any step.
Skipping titration steps is not recommended. Each step is designed to let your body gradually adapt, reducing the risk of nausea, vomiting, and other GI side effects. Moving too quickly may make side effects harder to tolerate and could lead to stopping the medication altogether, which would be counterproductive to your treatment goals.
If you miss a dose of liraglutide, take it as soon as you remember, provided your next scheduled dose is at least 12 hours away. If it is closer than that, skip the missed dose and resume your regular schedule. Do not take two doses in one day to make up for a missed one. Contact your prescriber with specific concerns.
The prescribing label does not formally require dose adjustments for renal impairment, but clinical caution applies for people with severe kidney disease. Liraglutide has not been well studied in patients on dialysis. If you have kidney disease, your prescriber will monitor you closely and may adjust how your overall treatment plan is managed.
The Bottom Line
Liraglutide dosing is a structured, stepwise process with different endpoints depending on whether you are using Victoza for type 2 diabetes or Saxenda for weight management. Both start at 0.6 mg to ease GI side effects, but the maintenance targets differ significantly. Real-world schedules are shaped by individual tolerance, kidney function, and other medications you may be taking. Understanding how and why each step works can help you stay on track and have more informed conversations with your care team. Doctronic offers free AI consultations and $39 video visits, available 24/7, if you want to discuss your liraglutide plan or tolerability concerns with a clinician. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get liraglutide dosing guidance
Chat Now